Pharmacist-led Continuous Glucose Monitoring
Start Date
9/1/2024
Completion Date
6/30/2026
Summary
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
FreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor
Conditions
Locations
USF Health Department of Family Medicine
Tampa, Florida 33612
United States